1. Qiuyue Xiao, Tianyuan Ye, Xiaolong Wang, Dongmei Qi, Xiaorui Cheng. Effects of Qi-FuYin on aging of APP/PS1 transgenic mice by regulating the intestinal microbiome, Frontiers in Cellular and Infection Microbiology, 2023,12:1048513.

2. Zou, Y.; Wang, Q.; Cheng X., Causal Relationship Between Basal Metabolic Rate and Alzheimer's Disease, A Bidirectional Two-sample Mendelian Randomization Study. Neurology and Therapy,2023

3. Xiao QiuYue, Ye TianYuan, Wang XiaoLong, Qi DongMei, Cheng XiaoRui. Effects of metformin on modulating the expression of brain-related genes of APP/PS1 transgenic mice based on Single Cell Sequencing, Current Alzheimer Research, 2022,19(11):754-771.

4. He Li, Weiqi Wei, Tianyuan Ye, Yiduan Liu, Dongmei Qi, Xiaorui Cheng. Identification of the

molecular subgroups in Alzheimer's disease by transcriptomic data. Frontiers in Neurology,

2022, 13:901179.

5. Liyuan Chen, Tianyuan Ye, Xiaolong Wang, Lu Han, Tongxing Wang, Dongmei Qi, Xiaorui

Cheng. Decoction on major depressive disorder based on network pharmacology and

molecular docking. Combinatorial Chemistry & High Throughput Screening, 2022.

6. Ying Yu, Gong Zhang, Tao Han, Hongjie Liu,Hailiang Huang. Potential Material Basis of Yupingfeng Powder for the Prevention and Treatmentof 2019 Novel Coronavirus Pneumonia: A Study Involving Molecular Docking andMolecular Dynamic Simulation Technology. Iotechnology Applied Microbiologymedicine, Research Experimental, 2022,7892397.

7. Ying Yu Gong Zhang, Tao Han, Hai-Liang Huang.Analysis of Herbal Mechanisms and Prescriptions for Chronic Cerebral Circulatory Insufficiency Based on Data Mining and Network Pharmacology.Comb Chem High Throughput Screen, 2022, 25(8):1239-1253.

8. Ying Yu Gong Zhang, Tao Han, Hai-Liang Huang. Network meta-analysis of heat-clearing and detoxifying oral liquid of Chinese medicines in treatment of children's hand-foot-mouth disease: A protocol for systematic review and meta-analysis, Medicine, 2022, 101(5):e28778.

9. Qiu-yue Xiao, Tian-yuan Ye, Xiao-long Wang, Lu Han, Tong-xing Wang, Dong-mei Qi, Xiao-rui Cheng, Sheng-qi Wang. A network pharmacology-based study on ey pharmacological pathways and targets of Qi Fu Yin acting on Alzheimer's disease. Experimental Gerontology, 2021, 149(1)

10. Hengyu Li , Hongwei Zhao,Yong Yang, Dongmei Qi, Xiaorui Cheng ,and Jiafeng Wang. Identification of Chemical Components of Qi-Fu-Yin and Its Prototype Components and Metabolites in Rat Plasma and Cerebrospinal Fluid via UPLC-Q-TOF-MS, Evidence-Based Complementary and Alternative Medicine, eCAM:2021.

11. Luo, D.; Han, L.; Gao, S.; Xiao, Z.; Zhou, Q.; Cheng, X.; Zhang, Y.; Zhou, W., LINCS Dataset-Based Repositioning of Dutasteride as an Anti-Neuroinflammation Agent. Brain Sci 2021, 11, (11).

12. Zhou, J. W.; Zhao, M.; Rang, W. L.; Zhang, X. Y.; Liu, Z. M.; Zhang, L. R.; Wang, T. X.; Wu, C. T.; Cheng, X. R.; Zhou, W. X., Proteome Profiling Identified Amyloid-beta Protein Precursor as a Novel Binding Partner and Modulator of VGLUT1. J Alzheimers Dis 2021, 81, (3), 981-1038

13. Zeng, J.; Zhang, X.; Wang, J.; Cheng, X.; Zhang, Y.; Zhou, W., Comparison of Donepezil, emantine, Melatonin, and Liuwei Dihuang Decoction on Behavioral and Immune Endocrine Responses of Aged Senescence-Accelerated Mouse Resistant 1 Mice. Front Pharmacol 2020, 11, 350.

14. Jianhui Wang#, Xi Lei#, Zongjie Xie, Xiaorui Zhang,Xiaorui Cheng*, Wenxia Zhou*, Yongxiang Zhang. CA-30, an oligosaccharide fraction derived from Liuwei Dihuang decoction, ameliorates cognitive deterioration via the intestinal microbiome in the senescence-accelerated mouse prone 8 strain.Aging, 2019, 11(11):3463-3486.

15. Zeng, J.; Cheng, B.; Huang, Y.; Zhang, X.; Wang, C.; Sun, N.; Liu, G.; Cheng, X.; Zhang, Y.; Zhou, W., Active Fraction Combination from Liuwei Dihuang Decoction (LW-AFC) Alleviated the LPS-Induced Long-Term Potentiation Impairment and Glial Cells Activation in Hippocampus of Mice by Modulating Immune Responses. Evid Based Complement Alternat Med, 2019, 3040972.

16. Wang, J.; Cheng, X.; Zhang, X.; Liu, G.; Wang, Y.; Zhou, W.; Zhang, Y., A combination of indomethacin and atorvastatin ameliorates cognitive and pathological deterioration in PrP-hAbetaPPswe/PS1(DeltaE9) transgenic mice. J Neuroimmunol 2019, 330, 108-115.

17. Cheng, X. R.; Qi, C. H.; Wang, T. X.; Zhou, W. X.; Zhang, Y. X., Characteristics of the traditional Liu-Wei-Di-Huang prescription reassessed in modern pharmacology. Chin J Nat Med 2019, 17, (2),

103-121.

18. Tongxing Wang#, Lu Han, Xiaorui Zhang, Rongrong Wu,Xiaorui Cheng*, Wenxia Zhou*, Yongxiang Zhang. Knowledge-Based Neuroendocrine Immunomodulation (NIM) Molecular Network Construction and Its Application, Molecules, 2018, 23, 1312.

19. Jianhui Wang#,Xiaorui Cheng#*, Ju Zeng, Jiangbei Yuan, Zhongfu Wang, Wenxia Zhou*, Yongxiang Zhang. LW-AFC Effects onN-glycan Profile in Senescence Accelerated Mouse Prone 8 Strain, a Mouse Model of Alzheimer’s Disease,Aging and Disease, 2017, 8(1): 101-114.

20. Jianhui Wang#, Xi Lei#,Xiaorui Cheng#*, Xiaorui Zhang, Gang Liu, Junping Cheng, Yiran Xu, Ju Zeng, Wenxia Zhou*, Yongxiang Zhang*. LW-AFC, a new formula derived from Liuwei Dihuang decoction, ameliorates behavioral and pathological deterioration via modulating the neuroendocrine-immune system in PrP-hAβPPswe/PS1ΔE9 transgenic mice.Alzheimer's Research & Therapy, 2016, 8(1):57-72.

21. Wenxia Zhou#,Xiaorui Cheng#, Yongxian Zhang*. Effect of Liuwei Dihuang decoction, a traditional Chinese medicinal prescription, on the neuroendocrine immunomodulation network,Pharmacology and Therapeutics, 2016, 162(4): 170-178.

22. Cheng Xiaorui#, Cui Xiuliang#, Zheng Yue, Zhang Guirong, Li Peng, Huang Huang, Zhao Yueying, Bo Xiaochen, Wang Shengqi, Zhou Wenxia*, Zhang Yongxiang*. A Co-Module Regulated by Therapeutic Drugs in a Molecular Subnetwork of Alzheimer’s Disease Identified on the Basis of Traditional Chinese Medicine and SAMP8 Mice.Current Alzheimer Research, 2015, 12(9): 870-885.

23. Xiao-rui Cheng#, Wen-xia Zhou*, Yong-xiang Zhang*. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer’s disease animal model,Ageing Research Reviews, 2014, 13:13-37.

24. Xiaorui Cheng#, Yu Zhou#, Wei Gu, Jie Wu, Aihua Nie, Junping Cheng, Jinwu Zhou, Wenxia Zhou*, Yongxiang Zhang*. The selective BACE1 inhibitorⅥa reduces Aβ production in cell and mouse model of Alzheimer’s disease,Journal of Alzheimers Disease, 2013, 37(4): 823-834.

25. Jin-Wu Zhou#,Xiao-Rui Cheng#, Jun-Ping Cheng, Wen-Xia Zhou*, Yong-xiang Zhang*. The β-secretase activity and mRNA expression in the brain of senescence-accelerated mice.Journal of Alzheimers Disease, 2012, 28(2):471-480.

26. Xiao-Rui Cheng#, Yong Yang, Wen-Xia Zhou*, Yong-Xiang Zhang. Expression of VGLUTs contributes to degeneration and acquisition of learning and memory. Neurobiology of Learning and Memory, 2011, 95(3):361-375.

27. Zhang Gui-rong#,Cheng Xiao-rui, Zhou Wen-xia, Zhang Yong-xiang*. Age-related expression of calcium/calmodulin-dependent protein kinase ii-α in the hippocampus and cerebral cortex of samp8 and its response to anti-alzheimer’s disease drugs,Neuroscience, 2009, 159(1): 308-315.

28. Xiao-Rui Cheng#, Wen-Xia Zhou*, Yong-Xiang Zhang, Dong-sheng Zhou, Rui-fu Yang, and Ling-Feng Chen. Differential gene expression profiles in the hippocampus of enescence-accelerated mouse,Neurobiology of Aging, 2007, 28 (4): 497-506.